InsightRX Surpasses 1,000 Hospital Deployments as the Most Widely Used AI Precision Dosing Software
SAN FRANCISCO, Dec. 4, 2025 /PRNewswire/ -- InsightRX today announced the company's AI precision dosing software is now deployed across...
Antimicrobial
Kane Biotech Announces Third Quarter 2025 Financial Results
WINNIPEG, Manitoba, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announced...
Kane Biotech Announces New Private Placement Offering
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, Nov. 27, 2025 (GLOBE...
Using Antibiotics Wisely. Making Them Responsibly.
NORTHAMPTON, MA / ACCESS Newswire / November 25, 2025 / You wake up with a sore throat and a fever....
MicrobiotiX and West Africa Centre for Innovative Research and Care in Ghana Sign MoU to Advance Clinical Development of Bacteriophage Therapeutics and Combat AMR·MDR in Africa
SEOUL, South Korea, Nov. 20, 2025 (GLOBE NEWSWIRE) -- MicrobiotiX, a company specializing in the development of novel bacteriophage therapeutics,...
Bitscopic appoints Kelly Echevarria, Pharm.D., BCIDP to advance VA antimicrobial stewardship with PraediAlert
After 25+ years in VA infectious diseases and national leadership, Echevarria joins Bitscopic to help VAMCs strengthen antimicrobial stewardship programs (ASP)...
Omnix Medical and Prevail Partners, LLC Announce Strategic and Financial Partnership
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / November 6, 2025 / Omnix Medical Ltd., P.C. ("Omnix Medical") and Prevail Partners, LLC...
Arkstone’s AI Clinical Decision Support Helps Treat Over 1 Million Patients
The milestone underscores Arkstone's leadership in machine learning (ML) and artificial intelligence (AI)-driven infectious disease clinical guidance and its expanding...
MicrobiotiX Receives IND Approval for Novel Bacteriophage Drug MP101
Korea’s First Bacteriophage IND Approved by the Ministry of Food and Drug Safety – Phase 1 Trial to Begin in...
MicrobiotiX Receives IND Approval for Novel Bacteriophage Drug MP101
Korea’s First Bacteriophage IND Approved by the Ministry of Food and Drug Safety – Phase 1 Trial to Begin in...
MicrobiotiX Receives IND Approval for Novel Bacteriophage Drug MP101
Korea’s First Bacteriophage IND Approved by the Ministry of Food and Drug Safety – Phase 1 Trial to Begin in...
Data presented at ACR Convergence 2025 highlight Sobi’s commitment to advancing care across rare and underserved inflammatory conditions
NASP data highlight reduction in disease burden among people living with uncontrolled gout Gamifant (emapalumab) data showed response rates in...
BioLab Holdings, Inc. Announces Investment in Cold Atmospheric Plasma Technology
Partnership Will Advance Portable Antimicrobial Solutions for Wound Care and Dermatology PHOENIX, Oct. 24, 2025 /PRNewswire/ -- BioLab Holdings, Inc.,...
CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath
BERKELEY HEIGHTS, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
FendX Files Provisional Patent for Novel Antimicrobial Nanoparticle Liquid Coating
Vancouver, British Columbia--(Newsfile Corp. - October 22, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company"...
VTT identifies new plant-based anti-inflammatory and anti-ageing ingredients for sustainable cosmetics
ESPOO, Finland, Oct. 15, 2025 /PRNewswire/ -- In a landmark collaborative project, scientists at the VTT Technical Research Centre of...
Pictor’s Proteomics Platform Offers Promising Advancement for Detecting Mycoplasma bovis in Cattle
New research highlights the Pictor PictVet™ Mycoplasma bovis IgG Multiplex ELISA's enhanced analytical performance through multiplexing and its potential to...
Theriva™ Biologics Announces Upcoming Presentations at Medical Meetings
- VCN-01 expanded mPDAC data from VIRAGE Phase 2b trial to be presented at ESMO 2025 - - SYN-004 Interim...
Immuron Q1 FY26 YoY growth
Sales Highlights (unaudited): Global•Q1 sales AUD$2.0 million up 34% on prior comparative period (pcp) Australia•Q1 sales AUD$1.6 million up 52% on...
Novo Nordisk Foundation commits up to DKK 200 million to fund new platform to strengthen global defence against future pandemics
COPENHAGEN, Denmark, Oct. 13, 2025 /PRNewswire/ -- The AI-powered Global Pathogen Analysis Platform aims to strengthen the pandemic preparedness globally....